Citigroup Slaps $70 Price Target on Teva, Highest on Street
April 01, 2014 at 12:57 PM EDT
On Tuesday, Citigroup raised the price target for Teva Pharmaceuticals (NASDAQ: TEVA) from $60 to $70. Copaxone is a “largely ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.